Consolidated Planning Corp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,627
Closed -$348K 182
2025
Q4
$348K Buy
+3,627
New +$352K 0.04% 165
2024
Q2
Sell
-50,940
Closed -$4.44M 200
2024
Q1
$4.44M Buy
50,940
+2,267
+5% +$193K 0.76% 47
2023
Q4
$4.01M Buy
48,673
+1,706
+4% +$130K 0.75% 41
2023
Q3
$3.68M Buy
46,967
+2,106
+5% +$176K 0.82% 41
2023
Q2
$3.95M Buy
44,861
+879
+2% +$75.7K 0.83% 39
2023
Q1
$3.55M Buy
43,982
+10,285
+31% +$838K 0.92% 38
2022
Q4
$2.62M Buy
+33,697
New +$2.73M 0.72% 43
2021
Q4
Sell
-497
Closed -$62K 291
2021
Q3
$62K Buy
+497
New +$64.3K 0.04% 149

Other funds holding MDT

Consolidated Planning Corp's MDT Position: Q1 2026 in Review

Consolidated Planning Corp sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,627 shares — an estimated $348K sold.

Consolidated Planning Corp first reported a position in MDT in Q3 2021 and held it in 8 quarters. The position peaked at $4.44M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Consolidated Planning Corp reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Consolidated Planning Corp sold 3,627 Medtronic shares in Q1 2026, an estimated $348K.
  • Consolidated Planning Corp first reported a position in Medtronic in Q3 2021 and held it in 8 quarters.
  • Consolidated Planning Corp's Medtronic position peaked at $4.44M in Q1 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Consolidated Planning Corp's 13F filing for Q1 2026, filed 16 Apr 2026.